Biosino Bio-Technology and Science Incorporation - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Chen Peng, was filed 15 Jul 2026.
Biosino Bio-Technology and Science Incorporation - H Shares: what insiders have been doing
Biosino Bio-Technology and Science Incorporation - H Shares is a listed company. Its insiders report their share dealings to HKEX. Between 8 November 2025 and 8 November 2026, 2 insiders published 10 filings.
No insider sold shares on the market over the period. Instead, the filings list 10 purchases totalling €1.2M, made by 2 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. Chen Peng filed the largest purchase, €793k, on 15 July 2026, which represents 3.5% of the company's market value.
For context, the typical company on the same exchange (median of 750 companies) published 5 filings over the same period, against 10 filings here. Since 2026, the database holds 10 purchases and no sales by insiders of the company.
The last insider purchase was made public on 15 July 2026, 116 days ago.
Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +7.8%Entry HK$2.80 · Close at T+90 HK$3.02
- +10.8%Entry HK$2.97 · Close at T+90 HK$3.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,860,176 shares@ HK$2.4743.48% mcap67.5% of flowShareXHKGHKEX:DA20260715E00324Canonical exit: 12 Oct 2026 (T+90)
- 940,000 shares@ HK$2.400.49% mcap21.1% of flowShareXHKGHKEX:DA20260715E00321Canonical exit: 13 Sept 2026 (T+90)
- 300,000 shares@ HK$2.400.16% mcap6.8% of flowShareXHKGHKEX:DA20260715E00322Canonical exit: 20 Sept 2026 (T+90)
- 200,000 shares@ HK$2.400.24% mcap4.6% of flowShareXHKGHKEX:DA20260715E00323Canonical exit: 4 Oct 2026 (T+90)
- 8,000 shares@ HK$6.47343.3% of flowShareXHKGHKEX:DA20260601E00020Canonical exit: 22 Apr 2026 (T+90)
- 10,000 shares@ HK$3.4528.9% of flowShareXHKGHKEX:DA20260601E00018Canonical exit: 9 Apr 2026 (T+90)
- 4,000 shares@ HK$3.1510.5% of flowShareXHKGHKEX:DA20260601E00016Canonical exit: 7 Apr 2026 (T+90)
- 2,000 shares@ HK$3.085.1% of flowShareXHKGHKEX:DA20260601E00015Canonical exit: 6 Apr 2026 (T+90)
- 2,000 shares@ HK$3.726.2% of flowShareXHKGHKEX:DA20260601E00017Canonical exit: 8 Apr 2026 (T+90)
- 2,000 shares@ HK$3.485.8% of flowShareXHKGHKEX:DA20260601E00019Canonical exit: 12 Apr 2026 (T+90)
10 of 10 declarations
About Biosino Bio-Technology and Science Incorporation - H Shares
Biosino Bio-Technology and Science Incorporation - H Shares is a company specializing in biotechnology and life sciences. It focuses on the development and commercialization of innovative products and services in the healthcare sector.